FOSUN PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

make any statement and expressly disclaim any liability for any damages whatsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

assumes no responsibility for any failure.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (a joint stock limited company incorporated in the People's Republic of China)

(Stock code: 02196)

Overseas regulatory announcement

This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

This is to set forth the "About

Announcement on the Progress of Providing Guarantees for Controlled Subsidiaries” is for reference only.

By order of the board of directors Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Chairman

Chen Yuqing

China, Shanghai

July 3, 2026

As at the date of this announcement, the executive directors of the Company are Mr. Chen Yuqing, Ms. Guan Xiaohui, Mr. Wen Deyong, Mr. Wang Kexin and Mr. Liu Yi; the Company The non-executive directors of the company are Mr. Chen Qiyu and Mr. Pan Donghui; the independent non-executive directors of the company are Mr. Yu Zishan, Mr. Wang Quandi, and Mr. Chen Mr. Penghui and Mr. Yang Yucheng; and the employee director of the Company is Ms. Yan Jia.

*For identification only

Securities code: 600196 Securities abbreviation: Fosun Pharma Announcement number: Lin 2026-094

Shanghai Shanghai Fufu Xingxing Medical and Pharmaceutical ((Group)) Co., Ltd.

Announcement on the progress of providing guarantees for controlling subsidiaries

The board of directors and all directors of the company guarantee that the contents of this announcement do not contain any false records or misleading statements.

or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its content.

Important content reminder:

 Guarantee objects and basic information

Name Fosun Industrial

The amount of this guarantee is equivalent to 350 million euros

As of July 3, 2026, Including this guarantee, this Equivalent to approximately RMB 7,249.83 million The actual guarantee provided by the Group to the guaranteed party 11 Guaranteed balance Is it within the pre-expected amount? Yes □No □Not applicable: ________

The secured party 1 is the guarantor (the Company). Is there a counter-guarantee for this guarantee? Capital subsidiary, no counter-guarantee arrangement is involved

Name Fosun Health

The amount of this guarantee is RMB 100 million

As of July 3, 2026, Including this guarantee, this Equivalent to approximately RMB 2,113.66 million The actual guarantee provided by the guaranteed party 22 Group Guaranteed balance Is it within the pre-expected amount? Yes □No □Not applicable: ________

Is there a counter-guarantee for this guarantee Yes □No □Not applicable: ________

Name Nantong Jianjia

The amount of this guarantee is RMB 15 million

As of July 3, 2026, Including this guarantee, this RMB 51.5 million The actual guarantee provided by the guaranteed party 33 Group Guaranteed balance

Is it within the pre-expected amount? Yes □No □Not applicable: ________

Is there a counter-guarantee for this guarantee Yes □No □Not applicable: ________

Name Nanjing Jianjia

The amount of this guarantee is RMB 20 million

As of July 3, 2026, Including this guarantee, this RMB 38.9 million The guarantee actually provided by the guaranteed party 44 Group Guaranteed balance

Is it within the pre-expected amount? Yes □No □Not applicable: ________

Is there a counter-guarantee for this guarantee Yes □No □Not applicable: ________

Name Shanghai Jianjia

The amount of this guarantee is RMB 20 million

As of July 3, 2026, Including this guarantee, this RMB 61 million The guarantee actually provided by the guaranteed party 55 Group Guaranteed balance Is it within the pre-expected amount? Yes □No □Not applicable: ________

Is there a counter-guarantee for this guarantee Yes □No □Not applicable: ________

 Accumulated guarantee situation

The cumulative amount of external guarantees exceeding the overdue period is RMB 0 As of September 33, 2002, 2002-26-66, including this sub-guarantee, Equivalent to RMB 23,757.8 million1 Internally, the actual amount of the Group's external guarantee guarantee amount The amount of external guarantee deposit accounted for 22002255 year 1122 month 3311 day 48.74% Proportion of the audited net assets of the Group In this guarantee, some of the assets and liabilities of the guaranteed party Risk warnings The rate exceeds 70%.

11. Overview of the guarantee situation ((11)) The basic situation of this sub-guarantee

12. On July 3, 2026, the holding subsidiary Fosun Industrial and the loan syndicate and the loan syndicate’s agent bank

HSBC signed the "Facility Agreement" (i.e. loan agreement), and Fosun Industrial submitted the loan agreement to the loan syndicate and

The application period for subsequent new loan banks (if any) according to the contract shall not exceed 5 years, and the principal shall not exceed the equivalent value of 35,000

million euro syndicated loan. On the same day, the Company signed the "Guarantee Contract One" with HSBC Bank, under which the Company The above-mentioned syndicated loans are provided with joint liability guarantee, and the guarantee period is from July 3, 2026 to the agreed date

The debt performance period ends three years after the expiration date.

2. On July 2, 2026, Fosun Health, its holding subsidiary, signed a "Comprehensive Credit Contract" with China Minsheng Bank.

Fosun Health applied for a credit line of RMB 100 million from China Minsheng Bank, with the credit period starting from 2026 From July 3 to July 2, 2027. On the same day, the company signed the "Guarantee Contract II" with China Minsheng Bank.

It is agreed that the Company will provide joint liability guarantee for Fosun Health's debts under the above credit line.

The period is three years from the expiration date of the agreed debt performance period.

The counter-guarantee measures for this guarantee include: (1) Fosun Health’s shareholders Li Qi, Hengsheng Industrial, Lin Jun

Jie respectively pledged his shares in Fosun Health. (2) Fosun Health’s indirect shareholders Ningbo Lixing and Ningbo Likun (both are indirect shareholding platforms for employees to participate in incentive plans) respectively pledged their respective holdings of Ningbo Liding 2

Partnership share, (3) other receivables pledged by Fosun Health.

1 Among them, foreign currencies are converted according to the relevant RMB exchange rate central parity announced by the People's Bank of China on that day, the same below. 2 is the shareholding platform of Fosun Health Equity Incentive Plan.

3. On July 2, 2026, Nantong Jianjia, its holding subsidiary, signed a "Fixed Asset Lending Agreement" with Nantong Rural Commercial Bank.

Loan Contract", Nantong Jianjia applied for a fixed asset loan of RMB 5 million from Nantong Rural Commercial Bank. The loan The period is from May 11, 2026 to June 21, 2029. On the same day, the holding subsidiary Jianjia Medical (system

The controlling shareholder of Nantong Jianjia) signed the "Guarantee Contract III" with Nantong Rural Commercial Bank, stipulating that Jianjia Medical will be the superior

The above-mentioned loan is provided with joint liability guarantee, and the guarantee period is three days from the expiration of the agreed debt performance period.

years.

4. On July 2, 2026, Jianjia Medical and Nantong Rural Commercial Bank signed "Guarantee Contract IV", stipulating that by Jianjia Medical will provide its holding subsidiary Nantong Jianjia from June 15, 2026 to May 10, 2029

During the period, the debts under the main financing contract signed with Nantong Rural Commercial Bank with a principal amount not exceeding RMB 10 million were

Provide a joint liability guarantee of the highest amount for services (including but not limited to working capital loans, etc.) with a guarantee period of

From July 2, 2026 to three years after the expiration of the debt performance period under the main contract.

Nantong Jianjia’s other shareholder, Nantong Kangjian, pledged its 30% equity interest in Nantong Jianjia and pledged to Nantong Jianjia Tongjianjia’s shareholding ratio provides counter-guarantee for the aforementioned guarantees 3 to 4.

5. On July 2, 2026, Nanjing Jianjia, its holding subsidiary, signed the "Maximum Credit Amount" with Bank of Nanjing.

Contract", Nanjing Jianjia applied for a credit line of RMB 10 million from the Bank of Nanjing, with the credit period starting from

From July 1, 2026 to June 30, 2027. On the same day, Jianjia Medical (controlled by Nanjing Jianjia)

shareholders) signed "Guarantee Contract Five" with Bank of Nanjing, stipulating that Jianjia Medical will provide Nanjing Jianjia with the above-mentioned grant. Debts under the credit line are guaranteed with the highest joint liability guarantee, and the guarantee period is the agreed debt performance period.

Three years from the date of expiration.

6. On July 2, 2026, its holding subsidiary Jianjia Rehabilitation issued a "Guarantee" to the Nanjing Branch of Bank of Jiangsu.

Letter", it is agreed that Jianjia Rehabilitation will be its holding subsidiary Nanjing Jianjia from June 2, 2026 to May 2027

The financing signed with Nanjing Branch of Bank of Jiangsu on March 27th with a principal amount not exceeding RMB 10 million The debts under the main contract are guaranteed with the maximum joint liability guarantee, and the guarantee period is from July 2, 2026

It starts and ends three years after the expiration of the debt performance period under the main contract.

Nanjing Jianjia plans to pledge a security deposit equal to the principal amount of the guaranteed debt to provide guarantees for items 5 to 6 mentioned above.

Provide counter guarantee.

7. On July 2, 2026, Jianjia Rehabilitation signed the "Guarantee Contract Six" with the Zhangjiang Branch of the Bank of Jiangsu.

It is agreed that Jianjia Rehabilitation will serve as its holding subsidiary Shanghai Jianjia from June 2, 2026 to May 27, 2027 During the period, it signed a main financing contract with the Zhangjiang Branch of the Bank of Jiangsu with a principal amount not exceeding RMB 10 million.

The debts under the same item are guaranteed with the highest joint liability guarantee, and the guarantee period is from July 2, 2026 to

The debt performance period under the main contract ends three years after the expiration date.

8. On July 2, 2026, Jianjia Rehabilitation and Shanghai Pudong Development Bank signed "Guarantee Contract Seven", stipulating that Jianjia Rehabilitation

Jia Rehabilitation and its holding subsidiary Shanghai Jianjia will be responsible for the period from June 25, 2026 to December 31, 2029. Provision of debt under the main financing contract signed with Shanghai Pudong Development Bank with a principal amount not exceeding RMB 10 million

The maximum amount of joint liability guarantee is guaranteed, and the guarantee period for each debt is from the expiration of the agreed performance period of the debt.

Three years from the date of completion.

Shanghai Jianjia’s other shareholder, Shanghai Pu Nian, will pledge its 10% equity interest in Shanghai Jianjia,

The shareholding ratio of Shanghai Jianjia provides a counter guarantee for the aforementioned guarantees 7 to 8.

((22)) Internal decision-making procedures for guarantee matters that have been implemented

The 25th meeting of the tenth session of the Board of Directors and the 2025 annual shareholders’ meeting of the Company have reviewed and approved the relevant resolutions respectively.

For the proposal on renewing and adding new guarantee lines of the Group, please refer to the Company’s March 25, 2026 and 2026

Published on June 17 in China Securities Journal, Shanghai Securities News, Securities Times and the Shanghai Stock Exchange website Relevant announcements issued by (https://www.sse.com.cn).

This guarantee is within the above-mentioned amount approved by the shareholders’ meeting and does not require separate approval by the board of directors or shareholders’ meeting.

Accurate.

((33)) Basic situation of guarantee estimates

Upon approval by the Company’s shareholders’ meeting, from the time of approval by the 2025 annual shareholders’ meeting (i.e. June 16, 2026)

From the end of the 2026 annual shareholders' meeting or any shareholders' meeting passes a resolution to revoke or change the authorization mentioned in this proposal As of the date of

But it is not limited to the fact that the company is a holding subsidiary 3. A holding subsidiary provides guarantees for other holding subsidiaries); at the same time,

3 Refers to wholly-owned and non-wholly-owned holding subsidiaries/units (including holding subsidiaries/units with an asset-liability ratio of more than 70% (including the principal amount)), the same below.

The shareholders' meeting authorizes the company's management and/or its authorized persons to provide, within the above-mentioned approved guarantee amount,

According to actual business needs, determine and adjust specific guarantee matters and sign relevant legal documents. As of July 3, 2026, the approved guarantee amount and its usage (including the

within) as follows:

Unit: RMB 10,000 yuan

Already approved Already used The remaining available The guaranteed party Guarantee guaranteed amount limit 44 Guaranteed guaranteed amount limit 44 The asset-liability ratio is less than 70% (excluding the original number) 3,000,000 308,494 2,691,506 of holding subsidiaries The asset-liability ratio is above 70% (including the principal amount) 500,000 3,500 496,500 of holding subsidiaries

Total total 33,,550000,,000000 331111,,999944 33,,118888,,000066

22. Basic information of the guaranteed party

((11)) Fufu Xingshi Industrial Industry

Legal person Type □Other______________ (please specify) Name Fosun Industrial Wholly owned subsidiary Listed company □Holding subsidiary Its shareholding status □shareholding companies □Other______________ (please specify)

Major shareholders and shareholding ratio: The company holds 100% of its equity Chairman of the Board Guan Xiaohui

Established on September 22, 2004 Place of registration: Hong Kong, China

Foreign investment, sales and consultation of Chinese and Western medicines, diagnostic reagents, and medical equipment products Business scope consulting services, and related import and export business. 2025 January-March 2026 Main financial indicators Project (Audited) (Unaudited) 4 According to the authorization of the shareholders’ meeting, according to business development needs, such as the guarantee line provided for holding subsidiaries with an asset-liability ratio of more than 70% (including the original amount) If there is any unused balance, the balance can be adjusted and used to provide guarantees for holding subsidiaries whose asset-liability ratio is less than 70% (excluding the original amount).

(Individual basis, based on Hong Kong’s total financial assets 213,957 215,716 Preparation of financial reporting standards) Total liabilities 79,090 72,451 Unit: 10,000 US dollars Net assets 134,867 143,265 Operating income 616 261 Net profit 6,185 3,324

((22)) Good health to the stars

Legal person Type □Other______________ (please specify) Name Fosun Health □Wholly owned subsidiary Listed companies Holding subsidiaries Its shareholding status □shareholding companies □Other______________ (please specify)

The Company, Ningbo Liding, Panli Qi, Lin JJ, Foshan Chanxi City Investment, Hang Seng Major shareholders Industrial and Foshan Changaocheng Venture Capital hold 85.7951%, 5.2224%, and and shareholding ratio 3.3335%, 2.4800%, 2.2331%, 0.4893%, 0.4466% equity Legal representative Hu Hang Unified social credit code 913101155665993901 Date of establishment: December 28, 2010 Place of registration: China (Shanghai) Pilot Free Trade Zone

Registered capital RMB 5,827,835,909 Company Type Other Limited Liability Company

General projects: engaged in technology development, technical consulting, and technology in the field of health technology technical services and technology transfer; engaged in the medical and health industry and related fields (medical Business scope health care industry, medical education industry) investment; accepting entrustment from medical and health institutions to engage in Hospital management, providing hospital management consulting (except brokerage). 2025 January-March 2026 Project (Audited) (Unaudited) Total assets 881,144 880,794 Key financial indicators (Single entity) Total liabilities 376,904 382,080 Unit: RMB 10,000 yuan Net assets 504,240 498,714 Operating income 14,393 1,843 Net profit 3,990 -5,569

((三三)) Nannan Tongjianjiajia

Legal person Type □Other______________ (please specify) Name Nantong Jianjia □Wholly owned subsidiary Listed companies Holding subsidiaries Its shareholding status □shareholding companies □Other______________ (please specify)

Major shareholders and shareholding ratios: Jianjia Rehabilitation and Nantong Kangjian hold 70% and 30% of its equity respectively. Legal representative Qiu Bin

Unified social credit code 91320602MADRTTKD61 Date of establishment: July 18, 2024

Place of registration: Nantong City, Jiangsu Province Registered capital RMB 56 million

Company Type Limited Liability Company Licensed items: medical services; catering services; food sales; Class III medical devices Machinery business (projects that require approval according to law can only be carried out after approval by relevant departments) Business activities, specific business projects are subject to approval results) General projects: hospitals Business scope Management; traditional Chinese medicine health care services (non-medical); sales of first-class medical devices; Parking lot services; business management consulting; elderly care services; remote health management services; Health consulting services (excluding diagnosis and treatment services); sales of second-class medical devices. 2025 January-March 2026 Project (Unaudited) (Unaudited) Total assets 16,807 16,743 Key financial indicators (Single entity) Total liabilities 13,181 13,275 Unit: RMB 10,000 yuan Net assets 3,626 3,468 Operating income 94 309 Net profit -1,146 -441

((44)) Nanjing Jingjian Jiajia

Legal person Type □Other______________ (please specify) Name Nanjing Jianjia □Wholly owned subsidiary Listed companies Holding subsidiaries Its shareholding status □shareholding companies □Other______________ (please specify)

Major shareholders Jianjia Rehabilitation and Jiangsu Xiang'eqing Food Trading Co., Ltd. hold 99.50% and and a shareholding ratio of 0.50% Legal representative Chen Haipeng

Unified social credit code 91320106302746668P Established on February 13, 2015

Place of registration Nanjing City, Jiangsu Province Registered capital RMB 12.5 million

Company Type Limited Liability Company Department of Internal Medicine, Surgery, Rehabilitation Medicine (Orthopedics and Joint Rehabilitation, Neurological Rehabilitation, Children’s Rehabilitation Department), Medical Laboratory Department; Clinical Chemistry Laboratory Major; Medical Imaging Department; X Business scope Line diagnosis major, ultrasonic diagnosis major, electrocardiogram diagnosis major; traditional Chinese medicine department; parking lot Management services; business management consulting services. 2025 January-March 2026 Project (Audited) (Unaudited) Total assets 17,936 18,351 Key financial indicators Total liabilities 11,060 11,488 (single caliber) Unit: RMB 10,000 yuan Net assets 6,876 6,863 Operating income 11,444 1,744 Net profit 970 63 ((55)) Shanghai Haijian Jiajia

Legal person Type □Other______________ (please specify) Name Shanghai Jianjia □Wholly owned subsidiary Listed companies Holding subsidiaries Its shareholding status □shareholding companies □Other______________ (please specify)

Major shareholders Jianjia Rehabilitation and Shanghai Pu Nian hold 90% and 10% of its shares respectively. and shareholding ratio Legal representative Chen Haipeng Unified social credit code 91310106MADHRYMD2C Date of establishment: April 17, 2024

Place of registration: Shanghai

Registered capital RMB 60 million Company Type Limited Liability Company

General projects: hospital management; conference and exhibition services (exhibitions abroad must be approved by relevant Department approval); retail of cosmetics; wholesale of cosmetics; sales of daily necessities; Chapter Sales of Class I medical devices; sales of Class II medical devices; professional cleaning, cleaning, Disinfection service; parking lot service; property management; intelligent robot sales; intelligence Sales of home consumer equipment; sales of wearable smart devices; sales of electronic products; Business scope: sales of health food (prepackaged); sales of formula foods for special medical purposes; injections Sales of textiles; sales of office supplies; sales of household appliances; sanitary products and general merchandise Sales of single-use medical supplies; Internet sales (except for businesses that require sales licenses) product). (Except for projects that require approval according to law, projects can be independently opened with a business license and in accordance with the law. business activities) licensed projects: medical services; catering services; food sales; Business of Category III medical devices.

2025 January-March 2026 Project (Audited) (Unaudited) Total assets 25,996 25,979 Key financial indicators (Single entity) Total liabilities 23,290 24,170 Unit: RMB 10,000 yuan Net assets 2,706 1,810 Operating income 196 379 Net profit -2,431 -903

3. Main contents of the guarantee document

((11)) ""Guarantee and Guarantee Contract Contract""

1. The Company will apply to the loan syndicate and subsequent new loan banks (if any) according to the contract for Fosun Industrial.

Please provide joint liability guarantee for syndicated loans with an equivalent value of no more than 350 million euros. 2. Guarantee scope: The debt principal, interest and other liabilities that Fosun Industrial shall repay/pay to the loan syndicate according to the contract.

He pays expenses etc.

3. Guarantee period: from July 3, 2026 to three years after the expiration of the agreed debt performance period

Stop. 4. Effectiveness: "Guarantee Contract One" will take effect from July 3, 2026.

((22)) ""Guarantee and Guarantee Contract Contract 22""

1. Under the credit line of RMB 100 million applied by the Company to China Minsheng Bank for Fosun Health

The debt is guaranteed by a joint liability guarantee. 2. Guarantee scope: The debt principal, interest and other liabilities that Fosun Health shall repay/pay to Minsheng Bank according to the contract.

He pays expenses etc.

3. Guarantee period: from the expiration of the agreed debt performance period (including expiration in accordance with the contract or early expiration)

Three years from date.

4. Effectiveness: "Guarantee Contract II" will take effect from July 2, 2026.

((33)) ""Guarantee Guarantee Contract 33""

1. Jianjia Medical applied for a fixed asset loan of RMB 5 million from Nantong Rural Commercial Bank for Nantong Jianjia

The payment is provided with a joint and several liability guarantee.

2. Guarantee scope: The debt principal, interest and debt that Nantong Jianjia should repay/pay to Nantong Rural Commercial Bank according to the agreement Other expenses payable, etc.

3. Guarantee period: three years from the expiration of the agreed debt performance period; if it is agreed to pay off in installments,

The guarantee period is three years from July 2, 2026 to the expiration date of the last debt payment period.

4. Effectiveness: "Guarantee Contract III" will take effect from July 2, 2026.

((44)) ""Guarantee and Guarantee Contract Contract 44""

1. Jianjia Medical serves Nantong Jianjia from June 15, 2026 to May 10, 2029

The debts under the main financing contract signed with Nantong Rural Commercial Bank with a principal amount not exceeding RMB 10 million (including

(including but not limited to working capital loans, etc.) to provide maximum joint liability guarantee.

2. Guarantee scope: The debt principal, interest and debt that Nantong Jianjia should repay/pay to Nantong Rural Commercial Bank according to the agreement

Other expenses payable, etc. 3. Guarantee period: from July 2, 2026 to the expiration of the debt performance period under the main contract (including

expires in accordance with the contract, expires in advance or extends) three years after the date.

4. Effectiveness: "Guarantee Contract IV" will take effect from July 2, 2026.

((55)) ""Guarantee Guarantee Contract 55""

1. The RMB 10 million credit line project applied by Jianjia Medical to Bank of Nanjing for Nanjing Jianjia

The maximum amount of joint and several liability guarantee is provided for the debts under the loan.

2. Guarantee scope: The debt principal, interest and other liabilities that Nanjing Jianjia shall repay/pay to Nanjing Bank in accordance with the agreement.

He pays expenses etc.

3. Guarantee period: from the expiration of the agreed debt performance period (including expiration according to the contract, early expiration or extension) period) three years from the date.

4. Effectiveness: "Guarantee Contract Five" will take effect from July 2, 2026.

((66)) "Certificate of Guarantee"

1. From June 2, 2026 to May 27, 2027, Jiang Jianjia Rehabilitation and Nanjing Jianjia Debts under the main financing contract with a principal amount not exceeding RMB 10 million signed by Bank of Jiangsu Nanjing Branch

Provide maximum joint and several liability guarantee.

2. Guarantee scope: the debt principal that Nanjing Jianjia shall repay/pay to Bank of Jiangsu Nanjing Branch according to the contract,

Interest and other expenses payable, etc.

3. Guarantee period: from July 2, 2026 to the expiration of the debt performance period under the main contract (including ends three years after the date of maturity, early maturity or extension); if it is agreed to pay off the debt in installments, the guarantee period

The period is from July 2, 2026 to three years after the expiration of the last debt payment period.

4. Effectiveness: The "Letter of Guarantee" will take effect from July 2, 2026.

((77)) ""Guarantee and Guarantee Contract Sixty-six""

1. From June 2, 2026 to May 27, 2027, Jiang Jianjia Rehabilitation and Shanghai Jianjia Debts under the main financing contract signed by Bank of Jiangsu Zhangjiang Branch with a principal amount not exceeding RMB 10 million

Provide maximum joint and several liability guarantee.

2. Guarantee scope: the debt principal that Shanghai Jianjia shall repay/pay to Jiangsu Bank Zhangjiang Branch according to the contract,

Interest and other expenses payable, etc.

3. Guarantee period: from July 2, 2026 to the expiration of the debt performance period under the main contract (including ends three years after the date of maturity, early maturity or extension); if it is agreed to pay off the debt in installments, the guarantee period

The period is from July 2, 2026 to three years after the expiration of the last debt payment period.

4. Effectiveness: "Guarantee Contract VI" will take effect from July 2, 2026.

((88)) ""Guarantee and Guarantee Contract Contract No. 77""

1. From June 25, 2026 to December 31, 2029, Jianjia Rehabilitation will work with Shanghai Jianjia

The debt under the main financing contract signed by Shanghai Pudong Development Bank with a principal amount not exceeding RMB 10 million provides the best High joint and several liability guarantee.

2. Guarantee scope: The debt principal, interest and other debts that Shanghai Jianjia shall repay/pay to Shanghai Pudong Development Bank according to the agreement.

He pays expenses etc.

3. Guarantee period: It should be calculated separately for each debt, that is, from the expiration of the agreed performance period of the debt

(including maturity according to the contract, early maturity or extension); if it is agreed to pay off the debt in installments, the guarantee shall be The guarantee period is three years from the expiration date of each debt payment period to the expiration date of the last debt payment period.

4. Effectiveness: "Guarantee Contract VII" will take effect from July 2, 2026.

5. Necessity and reasonableness of guarantee

This guarantee is a guarantee between the company and its holding subsidiaries and holding subsidiaries. The financing involved in the guarantee In order to meet the actual operating needs of the relevant holding subsidiaries, the risks of this guarantee are relatively controllable and have necessary

It is necessary and reasonable and does not harm the interests of the company and its shareholders.

55. Opinions of the Board of Directors meeting

This guarantee was approved by the company’s 2025 shareholders’ meeting for renewal and new guarantee amount of the group. occurs within the limit, when the board of directors reviewed the quota, it was considered that, given that the guaranteed party was limited to the company’s controlled subsidiaries,

The guarantees under this amount occurred due to the operating needs of the Group, and the guarantee risks are relatively controllable. Therefore, the directors

The meeting will agree on the guarantee amount and submit it to the shareholders' meeting for review. When the board of directors votes on the matter,

All directors (including independent non-executive directors) unanimously agreed.

According to the authorization of the company's 2025 annual shareholders' meeting, this guarantee does not require separate approval by the board of directors.

66. The cumulative number of external guarantees and guarantees and the number of overdue guarantees

As of July 3, 2026, including this guarantee, the Group’s actual external guarantee amount is equivalent to

Approximately RMB 23,757.8 million, accounting for approximately the Group’s audited listed assets on December 31, 2025

48.74% of the company’s shareholders’ net assets; all are between the company and its holding subsidiaries/units, and between the holding subsidiaries/units Guarantees that occur between units.

As of July 3, 2026, the Group had no overdue guarantees.

Seventy-seven, explain the meaning

Secured party 1. Refers to Fosun Industrial (Hong Kong) Co., Ltd. Fosun Industrial Secured party 2. Refers to Shanghai Fosun Health Technology (Group) Co., Ltd. Fosun Health Secured party 3. Refers to Nantong Jianjia Rehabilitation Hospital Co., Ltd. Nantong Jianjia

Secured party 4. Refers to Nanjing Jianjia Rehabilitation Hospital Co., Ltd. Nanjing Jianjia Secured party 5. Refers to Shanghai Jianjia Rehabilitation Hospital Co., Ltd. Shanghai Jianjia The Company refers to Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

The Group refers to the Company and its holding subsidiaries/units

(1) Mashreqbank P.S.C., Hong Kong Branch, (2) Natixis, Hong Kong Branch, (3) HSBC Bank

Bank, (4) Qatar National Bank (Q.P.S.C.), Hong Kong

Kong Branch, (5) Banco Bilbao Vizcaya Argentaria, S.A., Hong Kong Branch, (6)

Loan syndicate refers to Nanyang Commercial Bank, Limited, (7) The Korea Development Bank Hong Kong Branch,

(8) KDB Asia Limited, (9) Standard Chartered Bank (Hong Kong) Limited, (10) Bank of East Asia Limited

Company, (11) Chiyu Banking Corporation Limited,

and (12) Hang Seng Bank Limited Foshan Chanxi City Investment refers to Foshan Chancheng District Chanxi New City Investment and Construction Co., Ltd.

Foshan Changaocheng Venture Capital refers to Foshan Changaocheng Venture Capital Fund Partnership (Limited Partnership)

Hengsheng Industrial refers to Shenzhen Hengsheng Industrial Group Co., Ltd.

Jianjia Rehabilitation refers to Shanghai Jianjia Rehabilitation Technology Co., Ltd.

Jianjia Medical refers to Jianjia Medical Investment Management Co., Ltd.

Bank of Jiangsu Nanjing Branch refers to Bank of Jiangsu Co., Ltd. Nanjing Branch

Bank of Jiangsu Zhangjiang Branch refers to Bank of Jiangsu Co., Ltd. Shanghai Zhangjiang Branch

The Hongkong and Shanghai Banking HSBC refers to Corporation Limited Minsheng Bank refers to China Minsheng Banking Co., Ltd. Shanghai Branch

Bank of Nanjing refers to Nanjing Chengbei Branch of Bank of Nanjing Co., Ltd.

Nantong Kangjian refers to Nantong Kangjian Investment Partnership (Limited Partnership)

Nantong Rural Commercial Bank refers to Jiangsu Nantong Rural Commercial Bank Co., Ltd.

Ningbo Liding refers to Ningbo Liding Enterprise Management Partnership (Limited Partnership)

Ningbo Meishan Bonded Port Area Likun Enterprise Management Partnership (Limited Ningbo Likun refers to partnership)

Ningbo Meishan Bonded Port Area Lixing Enterprise Management Partnership (Limited Ningbo Lixing refers to partnership) Shanghai Pudong Development Bank refers to Shanghai Pudong Development Bank Co., Ltd. Changning Branch

Shanghai Pu Nian refers to Shanghai Pu Nian Medical Management Center (Limited Partnership)

On July 3, 2026, the company signed an agreement with HSBC Bank "Guarantee Contract One" refers to 《Guarantee》 On July 2, 2026, the company signed an agreement with Minsheng Bank Shanghai Branch "Guarantee Contract II" refers to "Maximum Guarantee Contract" signed

On July 2, 2026, Jianjia Medical signed an agreement with Nantong Rural Commercial Bank "Guarantee Contract Three" refers to "Guarantee Contract" On July 2, 2026, Jianjia Medical signed an agreement with Nantong Rural Commercial Bank "Guarantee Contract IV" refers to "Maximum Guaranteed Contract" On July 2, 2026, Jianjia Medical signed the "Final Agreement" with Bank of Nanjing. "Guarantee Contract Five" refers to High Guaranteed Contract》 Refers to July 2, 2026, Jianjia Rehabilitation and Jiangsu Bank Zhangjiang Branch "Guarantee Contract Six" "Maximum Guarantee Contract" signed Refers to the "Final Agreement" signed between Jianjia Rehabilitation and Shanghai Pudong Development Bank on July 2, 2026. "Guarantee Contract Seven" High Guaranteed Contract》 Refers to July 2, 2026, Jianjia Rehabilitation reported to Nanjing Branch of Bank of Jiangsu "Letter of Guarantee" "Maximum Joint and Several Liability Guarantee" issued

Announcement is hereby made.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

board of directors

July 3, 2026